http://shopping.postnewsmarketplace.com/ROP/ads.aspx?adid=7695799&advid=1030765&type=

Application of Magnetic Fields as Adjunctive Treatment for Type II Diabetes

http://clinicaltrials.gov/ct2/show/NCT00863954

This study is currently recruiting participants.
Verified by pico-tesla Magnetic Therapies, LLC, March 2009
First Received: March 17, 2009 No Changes Posted
Sponsored by: pico-tesla Magnetic Therapies, LLC
Information provided by: pico-tesla Magnetic Therapies, LLC
ClinicalTrials.gov Identifier: NCT00863954
Purpose

The purpose of this study is to see if using a device called the Resonator, that puts out a very low electromagnetic field, effects blood glucose and A1c levels in people with Type 2 Diabetes.

Condition Intervention Phase
Type II Diabetes Mellitus
Device: Resonator Device
Phase I

MedlinePlus related topics: Diabetes
U.S. FDA Resources
Study Type: Interventional
Study Design: Randomized, Double Blind (Subject, Outcomes Assessor), Dose Comparison, Parallel Assignment, Efficacy Study
Official Title: A Controlled Pilot Study of the Application of Magnetic Fields Using the Resonator in Adjunctive Management of Type 2 Diabetes

Further study details as provided by pico-tesla Magnetic Therapies, LLC:

Primary Outcome Measures:

* Reduction in blood glucose and A1c levels at endpoint compared to start [ Time Frame: Start point, 3 months and 6 months ] [ Designated as safety issue: No ]


Estimated Enrollment: 60
Study Start Date: January 2009
Estimated Study Completion Date: December 2009
Estimated Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Output A: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device
Output B: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device
Output C: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device
Output D: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device
Output E: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device
Output F: Active Comparator Device: Resonator Device
comparison of different parameter settings of electromagnetic fields using the Resonator Device

Detailed Description:

The purpose of this pilot study is to determine whether application of magnetic fields generated by the Resonator result in statistically significant reductions in finger stick blood glucose levels, serum glucose and hemoglobin A1c levels. The study will also investigate any induced changes in serum lipids and liver function tests as indirect markers of insulin resistance.
Eligibility

Ages Eligible for Study: 21 Years to 80 Years
Genders Eligible for Study: Both
Accepts Healthy Volunteers: No
Criteria

Inclusion Criteria:

* Current diagnosis of Type II Diabetes Mellitus with A1c level above the upper limit of normal
* Subject currently performs routine finger stick blood sugar testing
* Subject is ambulatory
* None or stable medication regimen without significant side effects for at least 6 months, willingness and ability to maintain the stable medication regimen throughout the course of the study.
* Hemoglobin A1c levels within a 0.8% range of patient mean A1c level for the last two documented determinations, that must be within 2 years of the baseline testing date.
* Willingness to test finger stick blood sugars according to protocol.
* Willingness to have lab test blood draws performed according to protocol
* Willingness to maintain stable diet and activity regimen for the duration of the study.
* Willing and able to abstain from partaking in any non-essential existing or new treatments to improve serum blood sugar levels.
* Adequate contraceptive measures for female subjects
* Male or female
* Any ethnic group
* Between 21 and 80 years of age

Exclusion Criteria:

* Change in medical regimen within 6 months prior to initiation of study
* Any signs of Type I diabetes
* Active infectious process within 3 weeks of study initiation causing wide fluctuations in finger stick blood sugar level.
* Change in BMI of greater than 6% within a 6 month period prior to study initiation
* Any planned revascularization procedure
* Symptomatic congestive heart failure
* Leg or foot ulceration or open wounds
* Gangrene
* History of intermittent claudication
* Hemodialysis
* Currently being treated for malignancy
* Currently being treated with oral or intravenous catabolic steroids.
* Reported consumption of more than 14 alcoholic drinks per week.
* Pregnant, breast feeding,or planning pregnancy prior to the end of participation.
* Developmental disability or cognitive impairment that would make it difficult for the subject to partake in the clinical study, including adequate comprehension of the informed consent form and ability to record the necessary measurements.
* Uncontrolled hypertension
* Uncontrolled atrial fibrillation or other uncontrolled arrythmias, e.g. tachycardia, bradycardia
* Uncontrolled seizure disorder
* Uncontrolled, unstable, or untreated medical conditions which may significantly impact the subjects health or ability to complete the entire study, in the opinion of the investigator

Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00863954

Contacts
Contact: Josette Pressler 303-795-3222 jopressler@comcast.net
Contact: Allen Braswell 303-795-3222 allen_braswell@mac.com

Locations
United States, Colorado
pico-tesla Magnetic Therapies Recruiting
Littleton, Colorado, United States, 80120
Contact: Josette Pressler 303-795-3222 jopressler@comcast.net
Contact: Allen Braswell 303 795-3222 allen_braswell@mac.com
Principal Investigator: Jerry Jacobson
Sponsors and Collaborators
pico-tesla Magnetic Therapies, LLC
More Information

No publications provided

Responsible Party: pico-tesla Magnetic Therapies, LLC ( Allen S. Braswell CEO, pico-tesla Magnetic Therapies, LLC )
Study ID Numbers: 08165-01
Study First Received: March 17, 2009
Last Updated: March 17, 2009
ClinicalTrials.gov Identifier: NCT00863954 History of Changes
Health Authority: United States: Institutional Review Board

Study placed in the following topic categories:
Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Endocrinopathy
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:
Metabolic Diseases
Diabetes Mellitus, Type 2
Diabetes Mellitus
Endocrine System Diseases
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on April 17, 2009

--------------------------------------------------------------------

Pico Tesla Magnetic Therapies LLC is the company which got the rights to the Jacobson Resonator technology after JRSE went into BK. Notice Jerry Jacobson is still involved.

Just thought this might be of some interest to former JRSE shareholders.

?

This is unusual. 3 UPC's in one day:

2008 Log

UPC# Date Title

013-08 PDF 74 KB 6/12/08 Jacobson Resonance Enterprises, Inc.
012-08 PDF 74 KB 6/12/08 Oasys Mobile, Inc.
011-08 PDF 78 KB 6/12/08 Prosoft Learning Corp.

http://www.finra.org/web/groups/rules_regs/documents/upc_notice/p038650.pdf

Attn: Trading and Market Making/Legal and Compliance/Operations/Systems

UNIFORM PRACTICE CODE ADVISORY (UPC # 013-2008) June 6, 2008 _

Jacobson Resonance Enterprises, Inc. – Common Stock (OTC: JRSE)
Notice has been received that the above Company’s Joint Plan of
Reorganization (Plan) filed under Chapter XI of the Federal Bankruptcy Code, became
effective on December 8, 2006. Pursuant to the Plan, holders of the above referenced
securities will not receive any distributions.

Members are reminded of their obligations under NASD Conduct Rule 2310 if
they continue to engage in transactions in the above security after the effective date.

Members are further advised that deliveries in settlement of contracts in the
OLD securities, which were executed prior to the announcement that the securities
had been deemed worthless, shall be evidenced by either a) the OLD security; or b) a
Letter of Indemnity which shall grant the purchaser any rights and privileges which
might accrue to the holders of the physical securities. Such deliveries shall operate to
close-out the contract and shall be settled at the existing contract price pursuant to
Uniform Practice Code Rule 11530.

Questions regarding this notice should be directed to: Corporate Data
Operations Department, 203.375.9609.



http://www.finra.org/RulesRegulation/PublicationsGuidance/UniformPracticeCodeAdvisories/2008UPCNotices/index.htm

JRSE
Outstanding 68,189,000
Anyone got any more current numbers?

Out of any logic - re-activation of the shell in February/08, increasing A/S to 750M - everything is set for the merger...
BOOM - stock deleted based on 2 years old plan of bankruptcy...
Totally ILLEGAL - plan had no mentions about cancellation of common stock... Owners (Allen Braswell, Jr. & Paul Hundredmark) have to be sued for trading of illegal shares since re-activation of the shell

WHats that mean alex?

SECURITY DELETIONS
Updated Symbol Company Name Effective Date Unit of
Trade Comments
13:52 ALTO Alto Group Holdings Inc. Common Stock 6/9/2008 100 Added to OTCBB (ALTO)**
13:52 ARWLQ Arch Wireless, Inc. Common Stock 6/9/2008 100 Plan of Bankruptcy effective 5/29/2002 **
13:52 BUEGF Burmis Energy Inc Common Shares (Canada) 6/9/2008 100 Acquired by Baytex Energy Trust (.1525 trust unit/sh) **
13:52 HOUL Houlihans Restaurant Group Common Stock 6/9/2008 100 Inactive Security **
13:52 JRSE Jacobson Resonance Enteprises, Ltd. Common Stock 6/9/2008 100 Plan of Bankruptcy effective 12/8/2006. **
13:52 OYSM Oasys Mobile, Inc. Common Stock 6/9/2008 100 Bankruptcy Plan effective 10/18/2007. **
13:52 POSOQ Prosoft Learning Corporation Common Stock 6/9/2008 100 Plan of Bankruptcy effective 6/12/2006 **
13:52 RWKSQ RailWorks Corporation Common Stock 6/9/2008 100 Inactive Security
13:52 TLCNZ Talcon, L.P. Depository Receipt 6/9/2008 100 Inactive Security **
13:52 WWZD Web Wizard, Inc. Common Stock 6/9/2008 100 Added to OTCBB (WWZD)**

It's hard to understand how this thing trades at all. They filed for bankruptcy awhile back and don't all the shares usually get canceled as part of that?

awfully quiet trading going on...multiply purchases @.0003...hmmm

oops, will keep quiet ;)

Shhhhhhhhhhhhhhhh! :*)

Friday was a "shell" day - TVCE, VSUS, ATVE, ...
JRSE should be next...

an assumption based on the time frame (2 months after activation of shell) and market conditions - with problems in real estate & mortgages, an easy way to raise the capital would be to shift one of the Cmark Companies - public.

Just checked my email and I sent CMark an inquiry on 08/29/2006 so the site has been redirected at least since them.

Good link. Thanks.

k thx

It's been redirected there for quite awhile. I tried emailing them when I first discovered it but received no reply. (I could probably find the date I emailed them if I search my mail but I'm guessing about a year ago.)

awesome some major movement coming

found recently, didn't check for awhile

Has JRSE always been redirected to this site.

http://investorshub.advfn.com/boards/read_msg.asp?message_id=28238626

As far as I know, the company went bankrupt awhile back. If you read back through this board, there appears to be someone who took over, probably to use the shell for another company to go public with.

how do you know this is our company

The potential on this stock is just growing everyday - feels

like a roller-coaster ride reaching it's high point and ready

to explode - it's been a loooong time now... time for some

action

What exactly does Jacobson Resonance do?

Company website: http://ccmark.com/

Value, where did you hear this rumor?

JRSE is up 100% already from 0.0003 to 0.0006. There is an rumor
some private biotechnology company may merge with JRSE very soon.
Last spike it went to 0.0033 within a day from 0.0003 anyway.

What is up here? Big trading volume! Will JRSE spike to 0.0028?
The highest price was 0.007 (two years ago).

What is it going to take to get this thing going? Not much

activity in the past couple of months...

yes I agree

looking at the historical trends it could skyrocket

if good news arrive...

JRSE hasn't had any filings for quite a while now

so it may just be that there are some "meaty" news pending

Got some yesterday. This looks very interesting.

today will ber awesome just showing up on radars

Something is cooking and I do smell $$$$$$$ here.imho Allen is master of his worked eom

I trade this one many many time years ago. I just wonder what's cooking here folks eom

I'm starting to think this has already been sold and we will see the fruits very soon

Allen S Braswell Jr

Director at
Medical Technology System, Inc.
St. Petersburg, Florida
TECHNOLOGY / COMPUTER PERIPHERALS
Director since January 2005

Track This Person

49 years old

Mr. Braswell has served as a director of MTS since 2005. In 2007, he became President of Pico-Tesla Magnetic Therapies, LLC. Mr. Braswell has been a member of the Board of Directors of Suntron Corp. (a publicly traded company) since 1998, and has served on its audit and governance committees and as chairman of a special committee representing minority stockholders in matters related to an earlier merger. Prior to that time, he was President of Jabil Global Services, Vice President of EFTC Services, President/CEO of Circuit Test Inc. and an attorney in practice with Tanney, Ford, Donahey, Eno and Mills, P.A. Mr. Braswell attended the U.S. Military Academy (West Point) and graduated from the University of Florida with a bachelor's degree in finance. He received his J.D. degree from University of Florida School of Law.
Cash Compensation (FY March 2007)
Salary n/a

Bonus n/a

O
T
H
E
R Latest FY other short-term comp. n/a

Latest FY other long-term comp. n/a

Latest FY long-term incentive payout n/a
Total n/a


Stock Options (FY March 2007)
Number of options Market value
exercised n/a n/a

unexercised n/a n/a

unexercisable n/a n/a
Total n/a n/a


Press Releases
02.27.08 Senior Military Officials and Members of Congress Join Trisha Yearwood and Dale Earnhardt, Jr. for Third Annual Challenge Champions Gala PR NewsWire

02.27.08 Regions Financial Corporation Names John C. Carson, Jr., Chief Executive Officer of Morgan Keegan & Company Business Wire

02.27.08 LexisNexis(R) Announces 182 Lawyers Receive Martindale-Hubbell(R) Peer Review Ratings(SM) Business Wire

02.21.08 Stanford Financial Group Breaks Ground on Caribbean Expansion PR NewsWire

02.20.08 Celevoke, Inc., a Current Technology Operating Company, to Form Joint Venture in Brazil with Crown Telecom Founder JR Pereira Business Wire

More News >

ST. PETERSBURG, Florida – February 16, 2005 – MTS Medication Technologies (AMEX:MPP) has named Allen Braswell, Jr., former President of Jabil Global Services, to its Board of Directors.

“With his distinguished business career and significant experience as a board member of Suntron Corp., Allen will be an extremely strong addition to our board,” says Todd Siegel, MTS President and CEO. “His experience growing a small family business into an international leader in its field will bring valuable insights to MTS.”

Braswell has been a member of the Board of Directors of Suntron Corp. (Nasdaq:SUNN) since 1998, including service on the audit and governance committees and as chairman of a special committee representing minority shareholders in matters related to an earlier merger. Prior to that time, he was President of Jabil Global Services, Vice President of EFTC Services, President/CEO of Circuit Test Inc. and an attorney in practice with Tanney, Ford, Donahey, Eno and Mills, P.A.

Braswell attended the U.S. Military Academy (West Point) and graduated from the University of Florida with a bachelor’s degree in finance. He received his J.D. degree from University of Florida School of Law.

Founded in 1984, MTS Medication Technologies (www.mts-mt.com) is an international provider of medication compliance packaging systems designed to improve medication dispensing and administration. MTS manufactures automated packaging machines and related consumables for prescription medications and nutritional supplements. The Company serves more than 3,000 institutional pharmacies in the long-term care and correctional facility markets, both domestically and internationally.

Less than one percent.

(1) Includes 14,000 shares of common stock subject to currently exercisable
options granted under the Company's Equity Incentive Plan.

(2) Represents shares of common stock subject to currently exercisable options
granted under the Company's 2000 Equity Stock Option Plan.
(3) Mr. Braswell's address is 159 Ranch Road, Evergreen, Colorado 80439.
Includes 213,684 shares held by the Allen S. Braswell, Jr. EFTC Family
Limited Partnership, of which Allen S. Braswell Jr and his spouse, Alma L.
Braswell, are the general partners, 11,000 shares held by the Allen S.
Braswell, Sr. Trust, of which Allen S. Braswell, Sr., Allen S. Braswell,
Jr.'s father, is the trustee, 182,029 shares held by the Allen S. Braswell,
Jr. and Alma L. Braswell as joint tenants with right of survivorship, 4,000
shares held by the Allen S. and Alma L. Braswell Family Limited
Partnership, 35,000 shares held by Circuit Test International, LP, of which
Braswell Investment Corporation (Allen S. Braswell, Jr. is President) is a
general partner and 546,088 shares held by Braswell GRIT Limited
Partnership of which Braswell Investment Corporation (Allen S. Braswell,
Jr. is President) is a general partner.

http://biz.yahoo.com/t/20/443.html

look at allen brasswell stock purchases
http://www.secform4.com/insider-trading/1047752.htm

December 12, 2007 - 6:00 PM EST

close Email this News Article
Your Name
Your Email
Friend's Name
Friend's Email
Receive Copy: yes

SUNN 1.14 0.00

Today 5d 1m 3m 1y 5y 10y



Suntron Corporation Completes 'Going Private' Transaction
PHOENIX, Dec. 12, 2007 (PRIME NEWSWIRE) -- Suntron Corporation ("Suntron") (Nasdaq:SUNN), a leading provider of integrated electronics manufacturing solutions, announced today that its 90% stockholder, SUNN Acquisition Corporation ("SUNN"), completed the privatization of Suntron first announced and described in a press release dated October 3, 2007. As a result of the transaction, the former common stockholders of SUNN now own 100% of Suntron's common stock, and public trading of Suntron's common stock has ceased.

"We believe the costs associated with being a public company in today's environment exceed the benefits for Suntron and we look forward to aligning our resources with the needs of our customers," stated Paul Singh, Suntron's President and Chief Executive Officer. "Customer satisfaction has been high, we are winning new business at a faster pace, and improvements made in our operating efficiencies will enhance our ability to deliver even better service to our customers," concluded Mr. Singh.

About Suntron Corporation

Suntron delivers complete manufacturing services and solutions to support the entire life cycle of products in the industrial, semiconductor capital equipment, aerospace and defense, networking and telecommunications, and medical markets. Headquartered in Phoenix, Arizona, Suntron operates five full-service manufacturing facilities and two quick-turn manufacturing facilities in North America. Suntron is involved in product design, engineering services, cable and harness production, printed circuit card assembly, box build, large scale and complex system integration, commercial off-the-shelf integration and test.

The Suntron Corporation logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=2268

Visit www.suntroncorp.com or call 888-520-3382 for more information.

CONTACT: Suntron Corporation
Paul Singh, President and CEO
Thomas B. Sabol, Chief Financial Officer
602-789-6600
ir@suntroncorp.com



Source: PrimeNewswire (December 12, 2007 - 6:00 PM EST)

News by QuoteMedia
www.quotemedia.com

BID:doms and auto at 0008
ASK:ubss and auto at 0010

Volume: 24,694,112 2 hours before close fyi Ant.

Guess it is waking up, anticipation for a possible merger? Time will tell, Ant.

Me too, only by a few minutes though...lol

What in the Sam Hill is going on? I missed all the action!

i will look into that..what year was the bk from

Seems like 001 is the new base for now, 20 million shares traded in 1 hour, cookin' hmm Ant.